Sign in

CIK 0001551306

  • Large accelerated filer

Progyny, Inc.

Sign in to watch
Ticker
PGNY
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272220139
Phone
+1 212-888-3124
Business address
1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Former names
Auxogyn, Inc., Auxogyn Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,674,844
in 10 filings, $22.0M under 10b5-1 plans

Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-02 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion +32,000 $3.95 $126K 255,900
2023-02-02 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −23,019 $36.18 $833K 232,881
2023-02-02 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −8,981 $36.86 $331K 223,900
2023-02-02 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −5,755 $36.18 $208K 142,659
2023-02-02 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −2,245 $36.86 $83K 140,414
2023-02-02 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Stock Option (Right to Buy) −32,000 1,290,820
2023-02-02 Schlanger David J Executive Chairman Exercise or conversion +100,000 $0.91 $91K 176,168
2023-02-02 Schlanger David J Executive Chairman Sale −61,048 $36.12 $2.2M 115,120
2023-02-02 Schlanger David J Executive Chairman Sale −38,952 $36.79 $1.4M 76,168
2023-02-02 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) −100,000 1,030,943
2023-02-01 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion +32,000 $3.95 $126K 255,093
2023-02-01 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −32,000 $35.14 $1.1M 223,093
2023-02-01 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −8,000 $35.14 $281K 148,414
2023-02-01 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Stock Option (Right to Buy) −32,000 1,322,820
2023-02-01 Schlanger David J Executive Chairman Exercise or conversion +100,000 $0.91 $91K 174,716
2023-02-01 Schlanger David J Executive Chairman Sale −100,000 $35.18 $3.5M 74,716
2023-02-01 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) −100,000 1,132,395
2023-01-31 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion +735 $3.95 $3K 223,828
2023-01-31 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −735 $35.00 $26K 223,093
2023-01-31 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −184 $35.00 $6K 156,414

Page 32 of 77 · 1,524 trades